Department of Urology

February 9, 2023

Mark Cuban pharmacy could save billions on prostate cancer, bladder drugs

Vanderbilt research found that a new drug company founded by entrepreneur Mark Cuban could save patients $1.29 billion a year based on 2020 Medicare Part D expenditures on just the nine most popular urological drugs.

By Craig Boerner
October 27, 2022

Study reveals pathways for aggressive prostate cancer subtype

Research from Vanderbilt-Ingram Cancer Center has revealed new information about the molecular pathways of cribriform prostate cancer.

By Tom Wilemon
September 26, 2022

Gender differences with bladder pain

Gender differences in the pain experiences and treatment needs of people with a urologic pain syndrome could be used to improve interventions, Vanderbilt researchers report.

By Leigh MacMillan
Maria Hadjifrangiskou, PhD, Connor Beebout, PhD, and colleagues are studying why the bacterium E. coli is so tenacious.
August 25, 2022

Study describes how E. coli co-opts cells, causes recurrent UTIs

Researchers at Vanderbilt University Medical Center have discovered why the uropathogenic bacterium E. coli, the leading cause of urinary tract infections, is so tenacious; their findings could lead to new ways to prevent recurrent UTIs.

By Bill Snyder
Scott Sullivant is one of the many patients being helped through VUMC’s REACH for Survivorship Clinic.
August 4, 2022

Clinic helps patients prepare to move beyond prostate cancer

Vanderbilt’s REACH for Survivorship Clinic takes a holistic approach to help treat prostate cancer patients.

By Craig Boerner
August 4, 2022

Female bladder cancer patients to benefit from new care support coordinator

A philanthropic gift of a patient care coordinator designated to assist female bladder cancer patients in education, clinical decision-making, surveillance, support and even screening, is the first of its kind at Vanderbilt University Medical Center.

By Craig Boerner
March 11, 2022

New Clinician Spotlight: Jeffrey Tosoian

Jeffrey Tosoian, MD, MPH, joined the Department of Urology at Vanderbilt University Medical Center recently after completing his fellowship at the University of Michigan.
By VUMC News and Communications
December 9, 2021

Prostate cancer treatment regret

Vanderbilt researchers suggest that to reduce treatment-related regret for men with localized prostate cancer, treatment preparation should focus on shared decision-making and aligning patient expectations with treatment toxicity.
By Leigh MacMillan
November 18, 2021

Program extends palliative care knowledge to improve patient care

A new resource at Vanderbilt is helping medical students, residents and even long-standing medical faculty to enhance their palliative care skills.
By Jill Clendening
October 19, 2021

Combo therapy slows prostate cancer

A new combination treatment showed promise in slowing the growth of castration-resistant prostate cancer in animal models, Vanderbilt researchers discovered.
By Leigh MacMillan
August 4, 2021

Stimson named CMO of Employee Health Plans

C.J. Stimson, MD, JD, assistant professor of Urology at Vanderbilt University Medical Center, has been named Chief Medical Officer (CMO) of the VUMC and Vanderbilt University Employee Health Plans.
By Matt Batcheldor
June 22, 2021

Treating metastatic prostate cancer

An indirect comparative effectiveness study using published data suggests that the targeted therapy olaparib should be re-evaluated for treating metastatic prostate cancer.
By Leigh MacMillan
April 14, 2021

Rodes and Patricia Hart establish second chair in Department of Urology

H. Rodes Hart, BA’54, and Patricia Ingram Hart, BA’57, whose generous gifts continue to advance the mission of Vanderbilt as one of the world’s great universities for learning and discovery, have endowed a second chair in Urologic Surgery.
By Ann Marie Deer Owens
1 2 3